Viridian Therapeutics, Inc.\DE (VRDN) Times Interest Earned (2013 - 2026)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Times Interest Earned came in at -$33.56 in Q1 2026, up 80.34% year-on-year from -$18.61 in Q1 2025, and up 10.28% quarter-over-quarter from -$37.4 in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Times Interest Earned (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Times Interest Earned history runs 14 years deep, the most recent figure standing at -$33.56 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 80.34% year-over-year to -$33.56 in Q1 2026; TTM through Mar 2026 was -$49.11, a 75.42% increase from a year earlier, with the FY2025 full-year figure at -$1.15, up 20.02% from the prior year.
- Times Interest Earned rose to -$33.56 in Q1 2026 per VRDN's latest filing, from -$37.4 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1962.6 in Q4 2022 and bottomed at -$624.8 in Q4 2024.
- The 5-year median for Times Interest Earned is -$103.14 (2024), against an average of -$28.49.
- Across the five-year window, Times Interest Earned jumped 1449.77% in 2022 and slumped 1228.72% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $1962.6 in 2022, then plunged by 109.1% to -$178.7 in 2023, then slumped by 249.65% to -$624.8 in 2024, then jumped by 94.01% to -$37.4 in 2025, then gained by 10.28% to -$33.56 in 2026.
- Per Business Quant, the three latest VRDN Times Interest Earned figures stand at -$33.56 (Q1 2026), -$37.4 (Q4 2025), and -$71.45 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | -33.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.56 |
| Dec 31, 2025 | -37.40 |
| Sep 30, 2025 | -71.45 |
| Jun 30, 2025 | -22.61 |
| Mar 31, 2025 | -170.67 |
| Dec 31, 2024 | -624.80 |
| Sep 30, 2024 | -5.38 |
| Jun 30, 2024 | -120.92 |
| Mar 31, 2024 | -51.38 |
| Dec 31, 2023 | -178.70 |
| Sep 30, 2023 | -85.37 |
| Jun 30, 2023 | -357.08 |
| Mar 31, 2023 | -362.37 |
| Dec 31, 2022 | 1,962.64 |
| Sep 30, 2022 | -148.93 |
| Jun 30, 2022 | -147.82 |
| Dec 31, 2021 | -145.41 |
| Mar 31, 2021 | -46.29 |
| Dec 31, 2020 | -888.22 |
| Sep 30, 2020 | -10.82 |